What is Sleep Number's earnings per share (EPS)?

Sleep Number (SNBR) reported diluted earnings per share of $-5.77 for fiscal year 2026. This represents a -541.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sleep Number Financials

SNBR

Source SEC Filings (10-K/10-Q) Updated Jan 3, 2026 Currency USD FYE January

This page shows Sleep Number (SNBR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.02x

For every $1 of reported earnings, Sleep Number generates $0.02 in operating cash flow (-$3.3M OCF vs -$132.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-0.9x

Sleep Number earns $-0.9 in operating income for every $1 of interest expense (-$46.6M vs $49.4M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.4B

YoY-16.1%

5Y CAGR-3.6%

10Y CAGR+3.9%

Sleep Number generated $1.4B in revenue in fiscal year 2026. This represents a decrease of 16.1% from the prior year.

EBITDA

$9.0M

YoY-89.9%

5Y CAGR-44.7%

10Y CAGR-22.9%

Sleep Number's EBITDA was $9.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 89.9% from the prior year.

Net Income

-$132.0M

YoY-549.0%

Sleep Number reported -$132.0M in net income in fiscal year 2026. This represents a decrease of 549.0% from the prior year.

EPS (Diluted)

$-5.77

YoY-541.1%

Sleep Number earned $-5.77 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 541.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$17.7M

YoY-586.3%

Sleep Number generated -$17.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 586.3% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

59.0%

YoY-0.6pp

5Y CAGR-2.9pp

10Y CAGR-3.7pp

Sleep Number's gross margin was 59.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.6 percentage points from the prior year.

Operating Margin

-3.3%

YoY-4.7pp

5Y CAGR-9.9pp

10Y CAGR-12.7pp

Sleep Number's operating margin was -3.3% in fiscal year 2026, reflecting core business profitability. This is down 4.7 percentage points from the prior year.

Net Margin

-9.3%

YoY-8.1pp

5Y CAGR-14.2pp

10Y CAGR-15.6pp

Sleep Number's net profit margin was -9.3% in fiscal year 2026, showing the share of revenue converted to profit. This is down 8.1 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$33.9M

YoY-25.0%

5Y CAGR-0.6%

10Y CAGR+13.6%

Sleep Number invested $33.9M in research and development in fiscal year 2026. This represents a decrease of 25.0% from the prior year.

Share Buybacks

$1.2M

YoY+57.9%

5Y CAGR-62.6%

10Y CAGR-29.9%

Sleep Number spent $1.2M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 57.9% from the prior year.

Capital Expenditures

$14.4M

YoY-38.7%

5Y CAGR-24.6%

10Y CAGR-15.4%

Sleep Number invested $14.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 38.7% from the prior year.

SNBR Income Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Revenue	$1.4B-16.1%	$1.7B-10.9%	$1.9B-10.7%	$2.1B+13.9%	$1.9B+9.3%	$1.7B
Cost of Revenue	$578.5M-14.9%	$679.5M-14.9%	$799.0M-12.4%	$912.0M+30.2%	$700.6M+8.4%	$646.4M
Gross Profit	$833.0M-16.9%	$1.0B-7.9%	$1.1B-9.5%	$1.2B+4.0%	$1.2B+9.9%	$1.1B
R&D Expenses	$33.9M-25.0%	$45.3M-18.9%	$55.8M-9.3%	$61.5M+50.4%	$40.9M+17.1%	$35.0M
SG&A Expenses	$130.7M-12.9%	$150.0M+2.3%	$146.6M-4.3%	$153.3M-3.6%	$159.0M+15.3%	$138.0M
Operating Income	-$46.6M-303.7%	$22.9M-0.3%	$22.9M-66.2%	$67.9M-63.3%	$184.9M+64.9%	$112.1M
Interest Expense	$49.4M+2.1%	$48.4M+13.3%	$42.7M+124.9%	$19.0M+312.7%	-$8.9M-177.0%	$11.6M
Income Tax	$36.0M+797.1%	-$5.2M-15.6%	-$4.5M-136.4%	$12.3M-66.6%	$36.8M+97.1%	$18.7M
Net Income	-$132.0M-549.0%	-$20.3M-33.0%	-$15.3M-141.8%	$36.6M-73.7%	$139.2M+70.1%	$81.8M
EPS (Diluted)	$-5.77-541.1%	$-0.90-32.4%	$-0.68-142.5%	$1.60-67.3%	$4.90+81.5%	$2.70

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$347.4M+1.3%	$342.9M+4.6%	$327.9M-16.6%	$393.3M+4.4%	$376.8M-11.7%	$426.6M+4.5%	$408.4M-13.2%	$470.4M
Cost of Revenue	$154.1M+12.1%	$137.5M+2.5%	$134.2M-12.1%	$152.7M+1.0%	$151.2M-9.5%	$167.1M+0.1%	$166.9M-14.1%	$194.3M
Gross Profit	$193.3M-5.9%	$205.4M+6.0%	$193.7M-19.5%	$240.5M+6.6%	$225.6M-13.1%	$259.5M+7.5%	$241.5M-12.6%	$276.2M
R&D Expenses	$6.3M-14.2%	$7.3M-22.2%	$9.4M-13.6%	$10.9M+2.3%	$10.7M+0.7%	$10.6M-8.6%	$11.6M-6.9%	$12.4M
SG&A Expenses	$30.7M-3.6%	$31.8M+7.4%	$29.6M-23.3%	$38.6M+1.0%	$38.2M+15.6%	$33.1M-16.4%	$39.6M+1.3%	$39.1M
Operating Income	-$8.1M+80.0%	-$40.3M-53653.3%	-$75K-104.1%	$1.9M-33.4%	$2.8M-67.1%	$8.4M+37.8%	$6.1M+10.4%	$5.5M
Interest Expense	$13.9M+9.4%	$12.7M+8.1%	$11.7M+5.9%	$11.1M-5.6%	$11.7M-2.6%	$12.1M-1.7%	$12.3M-0.2%	$12.3M
Income Tax	$36.6M+376.9%	-$13.2M-200.1%	$13.2M+2356.9%	-$585K+86.4%	-$4.3M-779.1%	-$489K+55.5%	-$1.1M-251.6%	$725K
Net Income	-$58.5M-47.0%	-$39.8M-59.1%	-$25.0M-189.3%	-$8.6M-85.3%	-$4.7M-48.8%	-$3.1M+37.9%	-$5.1M+32.5%	-$7.5M
EPS (Diluted)	N/A	$-1.73-58.7%	$-1.09-186.8%	$-0.38	N/A	$-0.14+36.4%	$-0.22+33.3%	$-0.33

SNBR Balance Sheet

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Total Assets	N/A	$860.8M-9.5%	$950.9M-0.3%	$953.9M+16.0%	$822.2M+2.0%	$806.0M
Current Assets	N/A	$181.3M-12.1%	$206.1M+4.2%	$197.8M+15.3%	$171.5M+6.9%	$160.4M
Cash & Equivalents	N/A	$1.9M-23.2%	$2.5M+41.7%	$1.8M-19.9%	$2.2M+40.5%	$1.6M
Inventory	N/A	$103.2M-10.6%	$115.4M+1.2%	$114.0M+38.5%	$82.3M-5.5%	$87.1M
Accounts Receivable	N/A	$17.5M-34.8%	$26.9M+3.3%	$26.0M+0.3%	$25.9M+29.8%	$20.0M
Goodwill	N/A	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M
Total Liabilities	N/A	$1.3B-5.8%	$1.4B0.0%	$1.4B+20.5%	$1.2B+19.6%	$965.5M
Current Liabilities	N/A	$908.0M-3.0%	$936.1M+0.7%	$929.8M+22.8%	$757.4M+27.3%	$594.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	-$451.6M-2.2%	-$441.9M-0.9%	-$438.2M-31.7%	-$332.6M-108.6%	-$159.4M
Retained Earnings	N/A	-$479.2M-4.4%	-$458.9M-3.4%	-$443.6M-33.2%	-$332.9M-108.4%	-$159.7M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$680.1M-9.3%	$749.4M-6.9%	$804.5M-3.9%	$836.8M-2.8%	$860.8M-0.4%	$864.7M-2.1%	$883.6M-2.7%	$908.5M
Current Assets	$150.0M-11.7%	$169.8M-3.3%	$175.5M+0.1%	$175.4M-3.3%	$181.3M+6.5%	$170.3M-4.0%	$177.4M-2.0%	$181.0M
Cash & Equivalents	$1.7M+33.9%	$1.3M-6.3%	$1.3M-20.2%	$1.7M-13.3%	$1.9M+22.5%	$1.6M-21.2%	$2.0M-2.3%	$2.1M
Inventory	$82.2M-8.5%	$89.8M-9.7%	$99.5M-4.3%	$103.9M+0.7%	$103.2M+10.9%	$93.0M-2.9%	$95.8M-5.0%	$100.9M
Accounts Receivable	$15.5M+11.5%	$13.9M-13.2%	$16.0M+12.6%	$14.2M-18.8%	$17.5M+2.9%	$17.0M-16.0%	$20.3M-7.1%	$21.8M
Goodwill	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M
Total Liabilities	$1.3B-1.0%	$1.3B-1.1%	$1.3B-0.7%	$1.3B-1.4%	$1.3B-0.1%	$1.3B-1.3%	$1.3B-1.8%	$1.4B
Current Liabilities	$912.5M+1.5%	$898.8M-0.5%	$903.2M-0.1%	$904.4M-0.4%	$908.0M+1.6%	$894.0M-0.7%	$900.6M-0.6%	$906.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$578.5M-11.0%	-$521.3M-8.5%	-$480.7M-5.2%	-$456.8M-1.2%	-$451.6M-0.6%	-$448.8M-0.4%	-$447.0M-0.2%	-$445.9M
Retained Earnings	-$611.2M-10.6%	-$552.6M-7.8%	-$512.9M-5.1%	-$487.8M-1.8%	-$479.2M-1.0%	-$474.5M-0.7%	-$471.4M-1.1%	-$466.3M

SNBR Cash Flow Statement

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Operating Cash Flow	-$3.3M-112.1%	$27.1M+400.7%	-$9.0M-125.0%	$36.1M-87.1%	$279.7M+47.8%	$189.2M
Capital Expenditures	$14.4M-38.7%	$23.5M-58.8%	$57.1M-17.9%	$69.5M+87.2%	$37.1M-37.4%	$59.2M
Free Cash Flow	-$17.7M-586.3%	$3.6M+105.5%	-$66.1M-98.4%	-$33.3M-113.7%	$242.6M+86.7%	$129.9M
Investing Cash Flow	-$17.7M+32.7%	-$26.3M+54.9%	-$58.4M+17.4%	-$70.6M-81.0%	-$39.0M+31.1%	-$56.6M
Financing Cash Flow	$20.7M+1537.4%	-$1.4M-102.1%	$68.1M+101.1%	$33.9M+114.2%	-$238.0M-79.5%	-$132.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$1.2M+57.9%	$768K-79.5%	$3.7M-94.2%	$64.2M-72.8%	$235.6M+42.7%	$165.1M

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$1.9M+129.5%	-$6.4M-266.3%	$3.8M+245.5%	-$2.6M+88.9%	-$23.7M-186.7%	$27.3M+367.0%	-$10.2M-130.3%	$33.7M
Capital Expenditures	$2.5M-34.3%	$3.8M+11.1%	$3.5M-24.9%	$4.6M-26.8%	$6.3M+100.0%	$3.1M-34.1%	$4.8M-48.8%	$9.3M
Free Cash Flow	-$643K+93.7%	-$10.2M-2861.8%	$369K+105.1%	-$7.2M+75.9%	-$30.0M-224.0%	$24.2M+261.2%	-$15.0M-161.4%	$24.4M
Investing Cash Flow	-$2.5M+34.3%	-$3.8M+43.0%	-$6.7M-46.4%	-$4.6M+26.8%	-$6.3M-110.5%	-$3.0M+37.3%	-$4.8M+61.1%	-$12.3M
Financing Cash Flow	$1.1M-89.4%	$10.1M+293.4%	$2.6M-63.1%	$7.0M-77.0%	$30.3M+222.5%	-$24.7M-265.6%	$14.9M+168.0%	-$22.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$194K+158.7%	$75K-80.3%	$381K-32.3%	$563K+1307.5%	$40K-65.5%	$116K+176.2%	$42K-92.6%	$570K

SNBR Financial Ratios

Metric	FY26	FY24	FY23	FY22	FY21	FY19
Gross Margin	59.0%-0.6pp	59.6%+1.9pp	57.7%+0.8pp	56.9%-5.4pp	62.3%+0.3pp	61.9%
Operating Margin	-3.3%-4.7pp	1.4%+0.1pp	1.2%-2.0pp	3.2%-6.8pp	10.0%+3.4pp	6.6%
Net Margin	-9.3%-8.1pp	-1.2%-0.4pp	-0.8%-2.5pp	1.7%-5.8pp	7.5%+2.7pp	4.8%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	-2.4%-0.8pp	-1.6%-5.4pp	3.8%-13.1pp	16.9%+6.8pp	10.2%
Current Ratio	N/A	0.20-0.0	0.220.0	0.21-0.0	0.23-0.0	0.27
Debt-to-Equity	N/A	-2.91+0.2	-3.15+0.0	-3.18+0.3	-3.47+2.6	-6.06
FCF Margin	-1.3%-1.5pp	0.2%+3.7pp	-3.5%-1.9pp	-1.6%-14.7pp	13.1%+5.4pp	7.6%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	55.6%-4.3pp	59.9%+0.8pp	59.1%-2.1pp	61.2%+1.3pp	59.9%-1.0pp	60.8%+1.7pp	59.1%+0.4pp	58.7%
Operating Margin	-2.3%+9.4pp	-11.8%-11.7pp	-0.0%-0.5pp	0.5%-0.3pp	0.7%-1.2pp	2.0%+0.5pp	1.5%+0.3pp	1.2%
Net Margin	-16.8%-5.2pp	-11.6%-4.0pp	-7.6%-5.4pp	-2.2%-1.0pp	-1.2%-0.5pp	-0.7%+0.5pp	-1.2%+0.4pp	-1.6%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-8.6%-3.3pp	-5.3%-2.2pp	-3.1%-2.1pp	-1.0%-0.5pp	-0.5%-0.2pp	-0.4%+0.2pp	-0.6%+0.3pp	-0.8%
Current Ratio	0.16-0.0	0.190.0	0.190.0	0.190.0	0.200.0	0.190.0	0.200.0	0.20
Debt-to-Equity	-2.18+0.3	-2.44+0.2	-2.67+0.2	-2.83+0.1	-2.91+0.0	-2.93+0.1	-2.98+0.1	-3.04
FCF Margin	-0.2%+2.8pp	-3.0%-3.1pp	0.1%+1.9pp	-1.8%+6.1pp	-8.0%-13.6pp	5.7%+9.3pp	-3.7%-8.9pp	5.2%

Similar Companies

Viomi Technology Co., Ltd. VIOT

$76.1M

$213.6M

$250.9M

$252.8M

$81.7M

Frequently Asked Questions

What is Sleep Number's annual revenue?

Sleep Number (SNBR) reported $1.4B in total revenue for fiscal year 2026. This represents a -16.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sleep Number's revenue growing?

Sleep Number (SNBR) revenue declined by 16.1% year-over-year, from $1.7B to $1.4B in fiscal year 2026.

Is Sleep Number profitable?

No, Sleep Number (SNBR) reported a net income of -$132.0M in fiscal year 2026, with a net profit margin of -9.3%.

What is Sleep Number's EBITDA?

Sleep Number (SNBR) had EBITDA of $9.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

What is Sleep Number's gross margin?

Sleep Number (SNBR) had a gross margin of 59.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Sleep Number's operating margin?

Sleep Number (SNBR) had an operating margin of -3.3% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Sleep Number's net profit margin?

Sleep Number (SNBR) had a net profit margin of -9.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Sleep Number's free cash flow?

Sleep Number (SNBR) generated -$17.7M in free cash flow during fiscal year 2026. This represents a -586.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Sleep Number's operating cash flow?

Sleep Number (SNBR) generated -$3.3M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Sleep Number's capital expenditures?

Sleep Number (SNBR) invested $14.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Sleep Number spend on research and development?

Sleep Number (SNBR) invested $33.9M in research and development during fiscal year 2026.

Does Sleep Number buy back shares?

Yes, Sleep Number (SNBR) spent $1.2M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Are Sleep Number's earnings high quality?

Sleep Number (SNBR) has an earnings quality ratio of 0.02x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Sleep Number cover its interest payments?

Sleep Number (SNBR) has an interest coverage ratio of -0.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.